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Abstract: The effect of mouse spleen cells immunized with either live or beta-propiolac-
tone (BPL)-inactivated rabies virus on the spread of rabies virus was studied in vitro.
Spleen cells from C3H/He mice immunized with approximately　5×107 focus forming
unit of either live or BPL-inactivated rabies virus (Flury-HEP strain) first showed a low
level of specific cell-mediated cytotoxicity on day 4 after immunization. The cytotoxicity
reached a peak on day 7 and then declined to a low level on day 14. In conjunction with
the development of this cytotoxic activity, immune spleen cells significantly suppressed
the virus spread in the virus-infected mouse neuroblastoma cells (strain N-18) as revealed
by the inhibition of virus specific fluorescent focussize during a 30hr of incubation period.
This activity was apparently due to the T lymphocyte populations of immune spleen cells
since the activity was not diminished by the depletion of plastic plate adherent cells from
spleen cells nor by passage of non-adherent spleen cells through nylon wool column.
However, it was abrogated by prior incubation of non-adherent spleen cells with anti-Thy-
1 serum and complement. In addition, neither antiviral neutralizing antibody, interferon
nor lymphotoxin was detected in the infected murine neuroblastoma cell culture fluid co-
cultivated with immune spleen cells. This activity was observed only when immune spleen
cells and virus infected cells shared at least one H-2 haplotype. This focus size reduction
activity was also observed in the spleen cells of mice immunized with BPL-inactivated
virus to the same degree as with live virus.




















Received for publication, November 30, 1980
210
る･





















(1976), Wiktor et al. (1977),三舟ら(1980 a)
による免疫牌細胞の標的細胞障害(℃ell-mediated
℃ytotoxi℃ity)試験, Lagrange et al･ (1978),
Tsiang and Lagrange (1980〕による遅延型過敏症






































ックウイバレスを　Mitune et al. (1980)の方法に従
って℃E細胞で増殖させたものを使用Lた･狂犬病
ウバイルルスの感染価は, Smith et al. (1977) oの方法
に従って迅速蛍光フォ-カスカウソト法で行ない
8 ×106 Focus forming unit (FFU)/mlであっ
た･ ℃VS株ほ, Vero細胞でタロ-ソ化したもの
をMNB細胞で増殖させ使用Lた･感染価ほ6 ×108



































































標的細胞障害試験: Mifune et al･ (1979)の方
法に従って行なった. MNB細胞に℃VS株を,
tiultipli℃ity of inre℃tion (m･ o･ i･〕を3にして




Target　℃ell (EバT〕の比を50: 1-100: 1とL
てマウス旗陛細胞またほ牌細胞を重層し　37-℃で
更に18時間培養した後,培養上清中の放射活性を測






























定量Lた(Mifune et al., 1980). LTほ　Simizu
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Days after immunization
Fig･ 1 Development of ℃elトmediated ℃ytotoxi℃
a℃tivity of叩Ieen Cells of mi℃e immu-



















































T able. 1 Antiviral activity of rabies virus immune cells of mice in virus-infected murine
neuroblastoma cells*
Effertnr r^lk F/T ratin** Specific cytotoxic Virus yield Reduction of
.LiiicCLUi Cello J-j/ i rd.HO à" j sn/~\ /"( T^T^TT/ i\ à" j-'j.





































The monolayers of murine neuroblastoma cells were infected with plaque-purified CVS
strain of rabies virus at a moi of 3FFU/cell. Four hr later, the effector cells, harvested
on day 7 after immunization, were carefully overlayed on the monolayers with varying E/T
ratio and incubated at 37C. After 20 hr, the cultures were frozen and thawed 3 times and
the supernatant fluids after low speed centrifuzation were assayed for the virus infectivity.
Effector to target cell ratio.
T cell enriched population from peritoneal exudate cells.

























































































Fig･ 2　Relation between virus inn℃ulum and
nu mber of fmores℃ent foci of rabies
virus in murine neuroblantoma r℃ells
t_





T able. 2 Effect of the number of spleen cells on rabies virus focus size in murine
neuroblastoma cells
Ratio of spleen Focus size* Reduction Analysis



























* Average number of cells an immunefluorescent focus consisted.
** Nonadherent spleen cells from non-immunemice.
*** Nonadherent spleen cells from mice 6 days after immunization with Flury-HEP strain of
rabies virus.
+ Not statistically significant.
Immunofluorescent focus of rabies virus infected murine neuroblastoma cells. The cells in
the 4-chamber slide were infected with 100 FFU per chamber of plaque purified rabies
virus. Four hr after infection, the cells were overlayed with either (A) non-immune
spleen cells or (B) rabies immune spleen cells and further incubated at 37C for 26hr.
After the incubation period, infected cells were harvested and fixed with cold acetone


































T able. 3 Characterization of focus size reduction activity of immune spleen cells in rabies
virus-infected murine neuroblastoma cells
E xpt. Effector cells
I mmunestatusto
rabies virus
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* Average number of cells an Immunofluorescent focus consisted.
** Ab(neutralizing antibody), IF(interferon) and LT(lymphotoxin) in infected culture media
were assayed as described in the text.











































T able. 4 Effect of the difference of virus-infected target cells on the focus size reduction
activity of rabies virus immune nonadherent spleen cells
Focussize* ^ j A i à" r
Target cells Reduction Analysis of
Non-immune Rabies immune rate(%) variance
MNB** 16.3 6.0 63.2 P<0.01
CER 36.8 24.6 33. 0 NSS***
* Average number of cells an immunofluorescent focus consisted.
** Murine neuroblastoma cells.





















T able. 5 Development of focus size reduction activity of spleen cells after immunization
with live or inactivated virus
Effector cells Stimulant



















Live virus 6 14. 1


















57.4     P<0.012
8.^









































* Average number of cells an immunofluorescent focus consisted.
** Ab(neutralizing antibody), IF(interferon) and LT(lymphotoxin) in infected culture media
were assayed as described in the text.
+ Not statistically significant.
++ Mice were received second i. p. injection 10 days after primary injection with the same
antigen.
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